BIO-key International, Inc. (NASDAQ:BKYI) Q2 2019 Earnings Conference Call August 15, 2019 10:00 AM ET CompanyParticipants Scott Mahnken - Vice President, Marketing Mike DePasquale - Chairman and Chief Executive Officer Ceci Welch - Chief Financial Officer Fred Corsentino - Chief Revenue Officer Conference CallParticipants Nehal Chokshi - Maxim group Operator Good morning, ladies and gentlemen. Thank you for standing by. And welcome to BIO-key International Second Quarter 2019 Conference Call. During the pr ...

U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE EXCHANGE ACT For the Transition Period from to Commission file number 1-13463 BIO-KEY INTERNATIONAL, INC. (Exact Name of Registrant as Specified in Its Charter) DELAWARE 41-1741861 (State or Other Jurisdiction of Incorporation of Organization) (IRS Emplo ...

BIO-key International, Inc. (NASDAQ:BKYI) Q1 2019 Earnings Conference Call May 16, 2019 10:00 AM ET Company Participants Scott Mahnken - Vice President, Marketing Mike DePasquale - Chairman and Chief Executive Officer Ceci Welch - Chief Financial Officer Fred Corsentino - Chief Revenue Officer Conference Call Participants Nehal Chokshi - Maxim group Operator Good morning, ladies and gentlemen. Thank you for standing by. Welcome to BIO-key International's First Quarter 2019 Conference Call. During the presen ...

U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE EXCHANGE ACT For the Transition Period from to Commission file number 1-13463 BIO-KEY INTERNATIONAL, INC. (Exact Name of registrant as specified in its charter) DELAWARE 41-1741861 (State or Other Jurisdiction of Incorporation of Organization) (IRS Employe ...

BIO-key International, Inc. (NASDAQ:BKYI) Q4 2018 Earnings Conference Call April 2, 2019 10:00 AM ET Company Participants Scott Mahnken - Vice President, Marketing Mike DePasquale - Chairman and Chief Executive Officer Fred Corsentino - Chief Revenue Officer Ceci Welch - Chief Financial Officer Conference Call Participants Josh Goltry - Maxim Group Richard Pew - Richard Pew Investment Counsel Operator Good morning, ladies and gentlemen. Thank you for standing by. Welcome to BIO-key International's Fourth Qu ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ___ TO ___ COMMISSION FILE NUMBER: 1-13463 BIO-KEY INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) DELAWARE 41-1741861 (State or other jurisdiction ...